OTCMKTS:HLUYY

H. Lundbeck A/S News Headlines

$30.96
+0.69 (+2.28 %)
(As of 06/24/2021 03:49 PM ET)
Add
Compare
Today's Range
$30.70
$30.96
50-Day Range
$30.06
$33.15
52-Week Range
$27.92
$43.05
Volume4,260 shs
Average Volume2,983 shs
Market Capitalization$6.17 billion
P/E Ratio17.59
Dividend Yield0.89%
Beta0.73

H. Lundbeck A/S (OTCMKTS HLUYY) News Headlines Today

SourceHeadline
H. Lundbeck A/S (OTCMKTS:HLUYY) Rating Reiterated by BarclaysH. Lundbeck A/S (OTCMKTS:HLUYY) Rating Reiterated by Barclays
americanbankingnews.com - June 16 at 4:08 PM
H. Lundbeck A/S (OTCMKTS:HLUYY) Given Average Rating of "Hold" by AnalystsH. Lundbeck A/S (OTCMKTS:HLUYY) Given Average Rating of "Hold" by Analysts
americanbankingnews.com - June 13 at 5:28 AM
Harvards Wyss Institute initiates industry partnership to facilitate brain-targeted drug deliveryHarvard's Wyss Institute initiates industry partnership to facilitate brain-targeted drug delivery
markets.businessinsider.com - June 10 at 8:59 AM
Lundbeck to Showcase New VYEPTI® (eptinezumab-jjmr) Data at 63rd Annual Scientific Meeting of the American Headache Society (AHS)Lundbeck to Showcase New VYEPTI® (eptinezumab-jjmr) Data at 63rd Annual Scientific Meeting of the American Headache Society (AHS)
nz.finance.yahoo.com - June 3 at 9:37 AM
H. Lundbeck A/S 2021 Q1 - Results - Earnings Call PresentationH. Lundbeck A/S 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 11 at 1:56 PM
Lundbeck beats first quarter sales expectations, keeps outlookLundbeck beats first quarter sales expectations, keeps outlook
finance.yahoo.com - April 22 at 10:57 PM
Otsuka and Lundbeck Announce Decision to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients With Alzheimers-type DementiaOtsuka and Lundbeck Announce Decision to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients With Alzheimer's-type Dementia
businesswire.com - April 13 at 8:32 AM
Depression Treatment Market Share Worth USD 16.06 Billion by 2027, Market trends – in Increase in depression among millennialsDepression Treatment Market Share Worth USD 16.06 Billion by 2027, Market trends – in Increase in depression among millennials
marketwatch.com - April 2 at 6:37 AM
H. Lundbeck A/S (HLUYY)H. Lundbeck A/S (HLUYY)
au.finance.yahoo.com - March 24 at 7:45 PM
Benzodiazepine Market Analysis By Business Share, Development Trends, Segmentation, Opportunities and Forecast to 2025Benzodiazepine Market Analysis By Business Share, Development Trends, Segmentation, Opportunities and Forecast to 2025
marketwatch.com - March 22 at 7:23 AM
Dual Chamber Prefilled Syringes Market Size to Reach USD 223.3 Million By 2028: CAGR of 7.0% | Reports And DataDual Chamber Prefilled Syringes Market Size to Reach USD 223.3 Million By 2028: CAGR of 7.0% | Reports And Data
finance.yahoo.com - March 18 at 12:24 PM
Depression Treatment Market Size- Industry Share, Growth, Trends and Forecast 2027Depression Treatment Market Size- Industry Share, Growth, Trends and Forecast 2027
marketwatch.com - March 17 at 8:49 AM
Depression Treatment Market High Demand, Recent Trends, Future Growth, Industry Analysis, Forecasts Research, Top Manufacturers and Outlook 2027Depression Treatment Market High Demand, Recent Trends, Future Growth, Industry Analysis, Forecasts Research, Top Manufacturers and Outlook 2027
marketwatch.com - March 14 at 7:14 PM
Antipsychotic Drugs Market Research Report by Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19Antipsychotic Drugs Market Research Report by Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
finance.yahoo.com - March 11 at 9:33 AM
Lundbeck Will Benefit From Post-Pandemic Normalization, But The Rexulti Agitation Study Is Key To OutperformanceLundbeck Will Benefit From Post-Pandemic Normalization, But The Rexulti Agitation Study Is Key To Outperformance
seekingalpha.com - March 9 at 8:17 PM
Global Alzheimers Disease Treatment Market Report 2020: 2015-2019, 2023F, 2025F, 2030FGlobal Alzheimer's Disease Treatment Market Report 2020: 2015-2019, 2023F, 2025F, 2030F
benzinga.com - February 3 at 6:45 AM
Heres what Wall Street expects from H Lundbeck A-Ss earnings reportHere's what Wall Street expects from H Lundbeck A-S's earnings report
markets.businessinsider.com - February 2 at 5:44 PM
H Lundbeck A-S (spons ADRs) earnings preview: what Wall Street is expectingH Lundbeck A-S (spons ADRs) earnings preview: what Wall Street is expecting
markets.businessinsider.com - February 2 at 12:44 PM
Alzheimers Treatment Market Report by Industry Size 2021 Share, Top Key Players, Price, Revenue and Growth Rate and Business Insights Forecast 2027Alzheimers Treatment Market Report by Industry Size 2021 Share, Top Key Players, Price, Revenue and Growth Rate and Business Insights Forecast 2027
marketwatch.com - January 28 at 1:31 PM
Discover Major Depressive Disorder Drug Market To Grow At A Much Faster Rate Beyond 2020| Financial Analysis And ForecastDiscover Major Depressive Disorder Drug Market To Grow At A Much Faster Rate Beyond 2020| Financial Analysis And Forecast
marketwatch.com - January 28 at 8:30 AM
Major Depressive Disorder Drug Market Size 2021 by Regional Production Volume, Opportunities, Revenue, Growth Rate and Forecast to 2025Major Depressive Disorder Drug Market Size 2021 by Regional Production Volume, Opportunities, Revenue, Growth Rate and Forecast to 2025
marketwatch.com - January 15 at 9:30 AM
Lennox-Gastaut Syndrome Treatment Market 2021 to 2024: Analysis Includes Key Developments, Market Share and Size 360 Market UpdatesLennox-Gastaut Syndrome Treatment Market 2021 to 2024: Analysis Includes Key Developments, Market Share and Size 360 Market Updates
marketwatch.com - January 15 at 2:07 AM
Anti-Suicide Drugs Market Size 2020 by Capacity, Production, Revenue, Price, Cost, Gross Margin Analysis and Forecast to 2024Anti-Suicide Drugs Market Size 2020 by Capacity, Production, Revenue, Price, Cost, Gross Margin Analysis and Forecast to 2024
marketwatch.com - January 12 at 2:53 AM
Alzheimers Treatment Market Analysis 2020-2027 by Latest Trends, Leading Key Players, Future Growth, Revenue Analysis, Demand ForecastAlzheimers Treatment Market Analysis 2020-2027 by Latest Trends, Leading Key Players, Future Growth, Revenue Analysis, Demand Forecast
marketwatch.com - January 1 at 12:26 AM
H. Lundbeck A-S Stock , HLUKFH. Lundbeck A-S Stock , HLUKF
markets.businessinsider.com - December 25 at 11:41 PM
News for H. Lundbeck A-SNews for H. Lundbeck A-S
markets.businessinsider.com - December 24 at 9:45 AM
Schizophrenia Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Schizophrenia Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - December 17 at 3:08 PM
H. Lundbeck A/S to Host Earnings CallH. Lundbeck A/S to Host Earnings Call
finance.yahoo.com - November 3 at 2:43 PM
Heres what Wall Street expects from H Lundbeck A-Ss earningsHere's what Wall Street expects from H Lundbeck A-S's earnings
markets.businessinsider.com - November 2 at 12:31 PM
H. Lundbeck A/S (Lundbeck) (HLUYY)H. Lundbeck A/S (Lundbeck) (HLUYY)
nasdaq.com - October 24 at 5:45 PM
H. LUNDBECK A/S Navne-Aktier DK (LDB.SG)H. LUNDBECK A/S Navne-Aktier DK (LDB.SG)
ca.finance.yahoo.com - October 16 at 12:48 PM
Sanofis MAA for Pompe Disease Candidate Gets EMAs AcceptanceSanofi's MAA for Pompe Disease Candidate Gets EMA's Acceptance
nasdaq.com - October 5 at 2:02 PM
Beta Secretase 1 Market Size, Share from 2020 to 2026: Challengers’ Is Threat To Face For Key Vendors Worldwide| Says Market Reports WorldBeta Secretase 1 Market Size, Share from 2020 to 2026: Challengers’ Is Threat To Face For Key Vendors Worldwide| Says Market Reports World
marketwatch.com - September 28 at 8:45 AM
Positive headline results from the Vyepti (eptinezumab-jjmr) RELIEF studyPositive headline results from the Vyepti (eptinezumab-jjmr) RELIEF study
finance.yahoo.com - August 31 at 1:41 PM
Beta Secretase 1 Market In-depth Analysis, Reviews and Study Report 2020-2026Beta Secretase 1 Market In-depth Analysis, Reviews and Study Report 2020-2026
marketwatch.com - August 20 at 9:51 AM
Anti-Epileptic Drugs Market Research By Growth, Competitive Methods And Forecast To 2026Anti-Epileptic Drugs Market Research By Growth, Competitive Methods And Forecast To 2026
marketwatch.com - August 19 at 1:11 PM
H. Lundbeck A/SH. Lundbeck A/S
reuters.com - August 17 at 5:41 AM
Lundbeck Seeing Healthy Double-Digit Growth From New Drugs, But The Pipeline Is Very ThinLundbeck Seeing Healthy Double-Digit Growth From New Drugs, But The Pipeline Is Very Thin
seekingalpha.com - August 14 at 1:47 PM
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2020 Results - Earnings Call TranscriptH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 2:17 PM
H. Lundbeck A/S 2020 Q2 - Results - Earnings Call PresentationH. Lundbeck A/S 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 13 at 9:17 AM
H Lundbeck A-S earnings preview: what to expectH Lundbeck A-S earnings preview: what to expect
markets.businessinsider.com - August 13 at 9:17 AM
Anti-Epileptic Drugs Market Study for 2020 to 2026 providing information on Key Players, Growth Drivers and Industry challengesAnti-Epileptic Drugs Market Study for 2020 to 2026 providing information on Key Players, Growth Drivers and Industry challenges
marketwatch.com - August 7 at 1:35 AM
Global Beta Secretase 1 Market 2020 Top Key Players, Market Size, Share, and Regions, Types and Applications Forecast to 2026Global Beta Secretase 1 Market 2020 Top Key Players, Market Size, Share, and Regions, Types and Applications Forecast to 2026
www.marketwatch.com - July 30 at 1:07 PM
Depression Therapeutics Market 2020 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2029Depression Therapeutics Market 2020 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2029
www.marketwatch.com - July 29 at 9:45 AM
Huntingtons Disease Therapeutics Market Research Report 2020 Growth, Recent Trends and Forecast to 2025Huntington's Disease Therapeutics Market Research Report 2020 Growth, Recent Trends and Forecast to 2025
www.marketwatch.com - July 24 at 8:48 AM
Khloe Kardashian Adds Biohaven’s Migraine Drug to Product ToutsKhloe Kardashian Adds Biohaven’s Migraine Drug to Product Touts
www.bloomberg.com - July 15 at 12:46 PM
Bayers Drug Meets Primary Endpoint in Renal Outcomes StudyBayer's Drug Meets Primary Endpoint in Renal Outcomes Study
finance.yahoo.com - July 10 at 12:49 PM
AstraZenecas sNDA for Brilinta Gets FDAs Priority ReviewAstraZeneca's sNDA for Brilinta Gets FDA's Priority Review
www.nasdaq.com - July 9 at 3:04 PM
Benzodiazepine Drugs Market Trends & Forecast by 2020-2024: Geographical Regions, Manufacturers, Type and ApplicationBenzodiazepine Drugs Market Trends & Forecast by 2020-2024: Geographical Regions, Manufacturers, Type and Application
www.marketwatch.com - July 3 at 2:42 PM
Brain Hemorrhage Treatment Market 2020 Manufacturers, Type & Application, Trend, Growth Opportunities by RegionsBrain Hemorrhage Treatment Market 2020 Manufacturers, Type & Application, Trend, Growth Opportunities by Regions
www.marketwatch.com - July 3 at 9:32 AM
This page was last updated on 6/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.